J B McGill
Overview
Explore the profile of J B McGill including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
659
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Seaquist E, Blonde L, McGill J, Heller S, Kendall D, Bumpass J, et al.
Diabet Med
. 2019 Dec;
37(5):752-759.
PMID: 31811662
Aim: To evaluate the effect of final HbA levels on the incidences of hypoglycaemia in participants with type 1 diabetes treated with inhaled Technosphere Insulin or subcutaneous insulin aspart, reported...
2.
Shah K, Clark B, McGill J, Mueller M
Physiotherapy
. 2014 Dec;
101(2):147-54.
PMID: 25442298
Objectives: To determine the severity of, and relationships between, upper extremity impairments, pain and disability in patients with diabetes mellitus, and to compare upper extremity impairments in patients with diabetes...
3.
McGill J, Vlajnic A, Knutsen P, Recklein C, Rimler M, Fisher S
Diabetes Res Clin Pract
. 2013 Nov;
102(3):167-74.
PMID: 24183259
Aim: To evaluate the effect of gender on clinical outcomes in people with type 2 diabetes mellitus (T2DM) receiving antidiabetes therapy. Methods: This is a pooled analysis from nine similarly...
4.
Hirsch I, Buse J, Leahy J, McGill J, Peters A, Rodbard H, et al.
Diabetes Obes Metab
. 2013 May;
16(3):206-14.
PMID: 23711193
Integrating patient-centered diabetes care and algorithmic medicine poses particular challenges when optimized basal insulin fails to maintain glycaemic control in patients with type 2 diabetes. Multiple entwined physiological, psychosocial and...
5.
Tobin G, Cavaghan M, Hoogwerf B, McGill J
Int J Clin Pract
. 2012 Oct;
66(12):1147-57.
PMID: 23061886
Background: Type 2 diabetes is a progressive disease that requires stepwise additions of non-insulin and insulin therapies to meet recommended glycaemic goals. The final stage of intensification may require prandial...
6.
McGill J
Int J Clin Pract Suppl
. 2010 Oct;
(167):28-34.
PMID: 20887302
Aims: To review the non-glycaemic effects of liraglutide, including potential improvements in body weight, systolic blood pressure (SBP) and pancreatic beta-cell function. Key Findings: Liraglutide induced weight loss of around...
7.
Rosenstock J, Fonseca V, McGill J, Riddle M, Halle J, Hramiak I, et al.
Diabetologia
. 2009 Jul;
52(9):1971-3.
PMID: 19609501
No abstract available.
8.
Rosenstock J, Fonseca V, McGill J, Riddle M, Halle J, Hramiak I, et al.
Diabetologia
. 2009 Jun;
52(9):1778-88.
PMID: 19526210
Aims/hypothesis: This long-term study was designed to further characterise the retinal safety profile of insulin glargine and human neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes mellitus....
9.
Bell D, Bakris G, McGill J
Diabetes Obes Metab
. 2008 Jun;
11(3):234-8.
PMID: 18564334
Context: Vasoconstricting beta-blocker use is associated with a reduction in HDL cholesterol, higher triglyceride, total cholesterol and LDL cholesterol levels, whereas carvedilol, a vasodilating beta-blocker, has not been associated with...
10.
Fonseca V, Bakris G, Bell D, McGill J, Raskin P, Messerli F, et al.
Diabet Med
. 2007 Apr;
24(7):759-63.
PMID: 17451422
Aims: To determine whether the beneficial effects of carvedilol on insulin resistance (IR) are affected by the concomitant use of insulin sensitizers [thiazolidinediones (TZDs) and metformin]. Methods: Changes in HbA1c...